Olanzapine treatment in anorexia nervosa: Case report

Psychiatria Danubina

Volumn 21, Issue 1, 2009, Pages 122-125

  Dadić Hero, Elizabeta ^a   Ružić, Klementina ^a   Pernar, Mirjana ^a   Kabalin, Milena ^a   Medved, Paola ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Anorexia nervosa; Olanzapine; Weight gain

Indexed keywords

OLANZAPINE; PAROXETINE;

ADOLESCENT; ANOREXIA NERVOSA; ANXIETY; CASE REPORT; CONFERENCE PAPER; DEFENSE MECHANISM; DEPRESSION; DRUG CHOICE; EVENING DOSAGE; FEAR; FEMALE; GROUP THERAPY; HUMAN; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MORNING DOSAGE; PSYCHOSIS; PSYCHOTHERAPY; REMISSION; SELF ESTEEM; WEIGHT GAIN;

ADOLESCENT; AMBULATORY CARE; ANOREXIA NERVOSA; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY WEIGHT; COMBINED MODALITY THERAPY; DEFENSE MECHANISMS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MMPI; PAROXETINE; PSYCHOTHERAPY;

EID: 63649125715     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Bissada H, Tasca GA, Barber AM, Bradwqin J: Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double- blind, placebo-controlled trial. Am J Psychiatry. 2008; 165:1281-8.
2. Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P: Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol. 2007; 22:197-204.
3. Bruce KR, Steiger H, Ng Ying Kin NM, Israel M: Reduced platelet 3H paroxetine binding in anorexia nevosa: relationship to eating symptoms and personality pathology. Psychiatry Res. 2006; 142:225-32.
4. Dennis K, Le Grange D, Bremer J: Olanzapine use in adolescent anorexia nervosa. Eat Weight Disord. 2006; 11:53-6.
5. Dunican KC, DelDotto D: The role of olanzapine in the treatment of anorexia nervosa. Ann Pharmacother. 2007; 41:111-5.
6. Mehler C, Wewetzer C, Schulze U, Warnke A, Theisen F, Dittmann RW: Olanzapine in children and adolescents with chronic anorexia nerosa. A study of five cases. Eur Child Adolesc Psychiatry. 2001; 10:151-7.
7. Papadopoulos FC, Ekbom A, Brandt L, Ekselius L: Excess mortality, causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry. 2009; 194:10-7.
8. Spettigue W, Buchholz A, Henderson K, Feder S, Moher S, Kourad K, Gaboury I, Norris M, Ledoux S: Evaluation of efficacy and safety of olanzapine as an adjunctive treatmentfor anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. BMC Pediatr. 2008; 31:8-4.
9. Wang TS, Chou YH, Shiah IS: Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30:306-9.